All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4)

    Thumbnail
    Citations
    Altmetric
    Author
    Iland, Harry; Bradstock, Ken; Supple, Shane; Catalano, Alberto; COLLINS, MARNIE; Hertzberg, Mark; Browett, Peter; GRIGG, ANDREW; FIRKIN, FRANK; Hugman, Amanda; ...
    Date
    2012
    Source Title
    Blood
    University of Melbourne Author/s
    Grigg, Andrew; Firkin, Frank; Filshie, Robin; Szer, Jeffrey; Seymour, John
    Affiliation
    The Sir Peter Maccallum Department Of Oncology
    Metadata
    Show full item record
    Document Type
    Journal Article
    Citations
    Iland, H., Bradstock, K., Supple, S., Catalano, A., Collins, M., Hertzberg, M., et al. (2012). All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4). Blood, 120(8).
    Access Status
    This item is currently not available from this repository
    URI
    http://hdl.handle.net/11343/32937
    Description

    C1 - Journal Articles Refereed
    Keywords
    Chemotherapy; Cancer and Related Disorders

    Export Reference in RIS Format     

    Collections